Capecitabine in combination with panitumumab is not the treatment of choice in older patients with metastatic colorectal cancer

被引：1
|
作者：
Liposits, Gabor [1 ,2 ,3 ]
Pfeiffer, Per [1 ,2 ,3 ]
机构：
[1] Odense Univ Hosp, Dept Oncol, JB Winslows Vej 4, DK-5000 Odense C, Denmark
[2] Univ Southern Denmark, Dept Clin Res, JB Winslows Vej 4, DK-5000 Odense C, Denmark
[3] Acad Geriatr Canc Res AgeCare, Odense, Denmark
来源：
JOURNAL OF GERIATRIC ONCOLOGY | 2022年 / 13卷 / 01期
关键词：
CETUXIMAB PLUS CAPECITABINE; ELDERLY-PATIENTS; CHEMOTHERAPY;
D O I：
10.1016/j.jgo.2021.09.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：114 / 115
页数：2
相关论文
共 50 条
  • [21] Spotlight on Panitumumab in Metastatic Colorectal Cancer
    Gillian M. Keating
    [J]. BioDrugs, 2010, 24 : 275 - 278
  • [22] Panitumumab (Vectibix) for metastatic colorectal cancer
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2007, 49 (1259): : 35 - 36
  • [23] The combination of capecitabine and bevacizumab as treatment for metastatic breast cancer
    Gradishar, William J.
    [J]. CANCER INVESTIGATION, 2007, 25 : 3 - 4
  • [24] Panitumumab confers QoL benefits on patients with metastatic colorectal cancer
    [J]. Nature Clinical Practice Oncology, 2008, 5 (3): : 123 - 124
  • [25] Panitumumab monotherapy in patients with previously treated metastatic colorectal cancer
    Hecht, J. Randolph
    Patnaik, Amita
    Berlin, Jordan
    Venook, Alan
    Malik, Lmtiaz
    Tchekmedyian, Simon
    Navale, Lynn
    Amado, Rafael G.
    Meropol, Neal J.
    [J]. CANCER, 2007, 110 (05) : 980 - 988
  • [26] CAPECITABINE AS FLUOROPIDIMIDINE OF CHOICE IN COMBINATION CHEMOTHERAPY FOR ADVANCED AND/OR METASTATIC GASTRIC CANCER
    Gomez-Martin, C.
    Sanchez, A.
    Conde, V.
    Hernando, B.
    Serrano, R.
    Perez, B.
    Safont, M. J.
    Reboredo, M.
    Lacasta, A.
    Falco, E.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 175 - 175
  • [27] Capecitabine maintenance therapy following docetaxel/capecitabine combination treatment. in patients with metastatic breast cancer
    Surmeli, Zeki Gokhan
    Varol, Umut
    Cakar, Burcu
    Degirmenci, Mustafa
    Arslan, Cagatay
    Piskin, Gonul Demir
    Zengel, Baha
    Karaca, Burcak
    Sanli, Ulus Ali
    Uslu, Ruchan
    [J]. ONCOLOGY LETTERS, 2015, 10 (04) : 2598 - 2602
  • [28] Phase II study of bevacizumab in combination with capecitabine as first line treatment in elderly patients with metastatic colorectal cancer (MCC)
    Vrdoljak, E.
    Omrcen, T.
    Hrabar, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [29] EFFICACY OF BEVACIZUMAB IN COMBINATION WITH CHEMOTHERAPY WITH IRINOTECAN AND CAPECITABINE (XELIRI) IN FIRST-LINE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER
    Ocvirk, J.
    Rebersek, M.
    Boc, M.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 129 - 129
  • [30] Phase II study of bevacizumab in combination with capecitabine as first-line treatment in elderly patients with metastatic colorectal cancer
    Vrdoljak, Eduard
    Omrcen, Tomislav
    Boban, Marijo
    Hrabar, Andina
    [J]. ANTI-CANCER DRUGS, 2011, 22 (02) : 191 - 197
12345